Actively Recruiting
Study of Hydrogen Water to Reduce Fatigue and Improve Function in Adults with Chronic Fatigue Syndrome Using Heart Rate Variability
Led by Stony Brook University · Updated on 2025-06-08
50
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the use of hydrogen water, an over-the-counter magnesium-based supplement, to treat fatigue-related symptoms and improve function in adults with myalgic encephalomyelitischronic fatigue syndrome MECFS. This pilot study aims to identify heart rate variability HRV as a biological marker that can predict who will benefit from hydrogen water treatment. The study focuses on whether hydrogen water can reduce fatigue and enhance physical function in this population. Participants will follow a 10-day graduated dosing schedule of hydrogen water, followed by a standard daily dose over 16 weeks. The treatment involves consuming hydrogen water prepared from the supplement, which is known for its antioxidant properties. Researchers expect to observe two groups among participants those who improve and those who do not, based on their HRV measurements. During the study, participants will be assessed for fatigue severity using the Fatigue Severity Scale at 12 months. Heart rate variability will be monitored as a key biological measure to track health and well-being. The study will evaluate changes in fatigue symptoms and physical functioning over the treatment period, with safety and health status observed throughout participation, which may last up to one year.
CONDITIONS
Brief Title
Hydrogen Water Intervention With Heart Rate Variability as an Outcome Biomarker in ME/CFS
Research Team
F
Fred Friedberg, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here